Hydroxychloroquine and COVID-19: a tale of populism and obscurantism

Type Journal Article Author Nathan Peiffer-Smadja Author Mathieu E. Rebeaud Author Anthony Guihur Author Yahya Mahamat-Saleh Author Thibault Fiolet URL https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30866-5/abstract Publication The Lancet Infectious Diseases ISSN 1473-3099, 1474-4457 Date 13/11/2020 Extra Publisher: Elsevier PMID: 33197384 Journal Abbr The Lancet Infectious Diseases DOI 10.1016/S1473-3099(20)30866-5 Library Catalog www.thelancet.com Language English Abstract We read with interest the article by Estella Ektorp, which describes the death threats received by Marcus Lacerda following a trial on chloroquine for COVID-19 in Brazil.1 We give Lacerda our full support and herein report our experience in France and Switzerland following publication of a meta-analysis2 on hydroxychloroquine, with or without azithromycin, for COVID-19. Short Title Hydroxychloroquine and COVID-19